000305685 001__ 305685
000305685 005__ 20251111115731.0
000305685 0247_ $$2doi$$a10.1038/s41698-025-01148-5
000305685 0247_ $$2pmid$$apmid:41203783
000305685 0247_ $$2pmc$$apmc:PMC12594912
000305685 037__ $$aDKFZ-2025-02308
000305685 041__ $$aEnglish
000305685 082__ $$a610
000305685 1001_ $$aHertel, Alexander$$b0
000305685 245__ $$aTargeting tumoral heterogeneity in lung cancer: a novel, CT-texture-guided targeted biopsy approach with exome sequencing.
000305685 260__ $$a[London]$$bSpringer Nature$$c2025
000305685 3367_ $$2DRIVER$$aarticle
000305685 3367_ $$2DataCite$$aOutput Types/Journal article
000305685 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1762779826_2549712
000305685 3367_ $$2BibTeX$$aARTICLE
000305685 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000305685 3367_ $$00$$2EndNote$$aJournal Article
000305685 520__ $$aSolid tumors like lung cancer show significant mutational heterogeneity. A biopsy captures only focal aspects, limiting conclusions about overall tumor biology. This prospective study correlated CT-based radiomics features with genomic profiles to optimize biopsy site selection. Lung cancer patients underwent CT imaging, radiomics analysis, targeted biopsies, and whole-exome sequencing. Twelve non-redundant features were extracted, with JointEntropy guiding biopsy targeting. In 7 of 12 patients, over 10% of mutations were exclusive to one biopsy. Clonal reconstruction showed heterogeneous profiles with over two subclonal processes in 67% of cases. Unsupervised clustering of radiomics features revealed two distinct groups separated by entropy features, of which the entropy-rich cluster was associated with STK11 mutations. Our study demonstrates that integrating radiomics with localized genomic analysis enhances the understanding of tumoral heterogeneity and may improve the targeting of advanced tumor regions for diagnostic sampling.
000305685 536__ $$0G:(DE-HGF)POF4-311$$a311 - Zellbiologie und Tumorbiologie (POF4-311)$$cPOF4-311$$fPOF IV$$x0
000305685 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000305685 7001_ $$aStreuer, Alexander$$b1
000305685 7001_ $$aDiehl, Steffen$$b2
000305685 7001_ $$0P:(DE-He78)69710617a4b47b0f55eec41c4d794eeb$$aBoch, Tobias$$b3
000305685 7001_ $$aNörenberg, Dominik$$b4
000305685 7001_ $$aStrittmatter, Anika$$b5
000305685 7001_ $$aZöllner, Frank G$$b6
000305685 7001_ $$aSchoenberg, Stefan O$$b7
000305685 7001_ $$aHofmann, Wolf-Karsten$$b8
000305685 7001_ $$0P:(DE-He78)1eee9e84c0f8c90a97fe40b6e8252a23$$aLoges, Sonja$$b9$$udkfz
000305685 7001_ $$aNowak, Daniel$$b10
000305685 7001_ $$aFroelich, Matthias F$$b11
000305685 773__ $$0PERI:(DE-600)2891458-2$$a10.1038/s41698-025-01148-5$$gVol. 9, no. 1, p. 342$$n1$$p342$$tnpj precision oncology$$v9$$x2397-768X$$y2025
000305685 909CO $$ooai:inrepo02.dkfz.de:305685$$pVDB
000305685 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)69710617a4b47b0f55eec41c4d794eeb$$aDeutsches Krebsforschungszentrum$$b3$$kDKFZ
000305685 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)1eee9e84c0f8c90a97fe40b6e8252a23$$aDeutsches Krebsforschungszentrum$$b9$$kDKFZ
000305685 9131_ $$0G:(DE-HGF)POF4-311$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vZellbiologie und Tumorbiologie$$x0
000305685 9141_ $$y2025
000305685 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bNPJ PRECIS ONCOL : 2022$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2024-04-10T15:43:48Z
000305685 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2024-04-10T15:43:48Z
000305685 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Anonymous peer review$$d2024-04-10T15:43:48Z
000305685 915__ $$0LIC:(DE-HGF)CCBYNV$$2V:(DE-HGF)$$aCreative Commons Attribution CC BY (No Version)$$bDOAJ$$d2024-04-10T15:43:48Z
000305685 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bNPJ PRECIS ONCOL : 2022$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2024-12-30
000305685 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2024-12-30
000305685 9201_ $$0I:(DE-He78)A420-20160331$$kA420$$lPersonalisierte Medizinische Onkologie$$x0
000305685 980__ $$ajournal
000305685 980__ $$aVDB
000305685 980__ $$aI:(DE-He78)A420-20160331
000305685 980__ $$aUNRESTRICTED